Nutrition Research and Practice

The Korean Nutrition Society (한국영양학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of sun exposure and dietary vitamin D intake on serum 25-hydroxyvitamin D status in hemodialysis patients

  • Lee, Yeon Joo (Department of Food and Nutrition, Hanyang University) ;
  • Oh, Il Hwan (Department of Nephrology, Hanyang University Seoul Hospital) ;
  • Baek, Hee Jun (Department of Nutrition, Hanyang University Seoul Hospital) ;
  • Lee, Chang Hwa (Department of Nephrology, Hanyang University Seoul Hospital) ;
  • Lee, Sang Sun (Department of Food and Nutrition, Hanyang University)
  • Received : 2014.09.01
  • Accepted : 2014.12.14
  • Published : 2015.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

BACKGROUND/OBJECTIVES: Vitamin D deficiency is common in hemodialysis patients. The aim of this study was to identify whether or not sun exposure and dietary vitamin D intake have effects on serum 25-hydroxyvitamin D (25(OH)D) status in hemodialysis (HD) patients. The objective was to identify the main determinants of serum vitamin D status in the study subjects. SUBJECTS/METHODS: A cross-sectional study of 47 HD patients (19 males and 28 females) was performed. We assessed serum 25(OH)D and $1,25(OH)_2D$ levels between August and September 2012 and analyzed the prevalence of vitamin D deficiency in HD patients. To evaluate the determinants of serum 25(OH)D levels, we surveyed dietary vitamin D intake, degree of sun exposure, and outdoor activities. To compare biological variables, serum 25(OH)D was stratified as below 15 ng/ml or above 15 ng/ml. RESULTS: Mean 25(OH)D and $1,25(OH)_2D$ levels were $13.5{\pm}5.8ng/ml$ and $20.6{\pm}11.8pg/ml$, respectively. The proportions of serum 25(OH)D deficiency (< 15 ng/ml), insufficiency (15-< 30 ng/ml), and sufficiency (${\geq}30ng/ml$) in subjects were 72.4%, 23.4%, and 4.3%, respectively. Prevalence of vitamin D deficiency in female patients was 78.6%, whereas that in males was 63.2% (P = 0.046). Vitamin D intake and sun exposure time were not significantly different between the two stratified serum 25(OH)D levels. Dietary intake of vitamin D did not contribute to increased serum 25(OH)D levels in HD patients. The main effective factors affecting serum 25(OH)D status were found to be the sun exposure and active outdoor exercise. CONCLUSIONS: Hypovitaminosis D is common in HD patients and is higher in females than in males. Sun exposure is the most important determinant of serum 25(OH)D status in HD patients.

Keywords

References

  1. Lee YM, Park SW, Kim JS, Wang JK, Kim JY, Park MS, Pyo HJ, Kwon YJ. 25-Hydroxyvitamin D status in patients with chronic kidney disease in a single center. Korean J Nephrol 2010;29:458-64.
  2. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen EI, Willnow TE. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999;96:507-15. https://doi.org/10.1016/S0092-8674(00)80655-8
  3. Liu W, Yu WR, Carling T, Juhlin C, Rastad J, Ridefelt P, Akerstrom G, Hellman P. Regulation of gp330/megalin expression by vitamins A and D. Eur J Clin Invest 1998;28:100-7. https://doi.org/10.1046/j.1365-2362.1998.00253.x
  4. Kim CS, Kim SW. Vitamin D and chronic kidney disease. Korean J Intern Med 2014;29:416-27. https://doi.org/10.3904/kjim.2014.29.4.416
  5. Ramos R, Alcazar R, Otero A, de Francisco AL, del Pino MD. Economic impact of vitamin D treatment on chronic kidney disease patients. Nefrologia 2011;31:528-36.
  6. Dusso A, Gonzalez EA, Martin KJ. Vitamin D in chronic kidney disease. Best Pract Res Clin Endocrinol Metab 2011;25:647-55. https://doi.org/10.1016/j.beem.2011.05.005
  7. Hsu CH, Patel S. Uremic plasma contains factors inhibiting 1 alpha-hydroxylase activity. J Am Soc Nephrol 1992;3:947-52.
  8. Krassilnikova M, Ostrow K, Bader A, Heeger P, Mehrotra A. Low dietary intake of vitamin D and vitamin D deficiency in hemodialysis patients. J Nephrol Ther 2014;4. pii: 166.
  9. Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, Gao YL, Takasu J, Adler S, Norris K. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 2008;3:1144-51. https://doi.org/10.2215/CJN.05781207
  10. Judd SE, Tangpricha V. Vitamin D therapy and cardiovascular health. Curr Hypertens Rep 2011;13:187-91. https://doi.org/10.1007/s11906-011-0190-2
  11. Sterling KA, Eftekhari P, Girndt M, Kimmel PL, Raj DS. The immunoregulatory function of vitamin D: implications in chronic kidney disease. Nat Rev Nephrol 2012;8:403-12. https://doi.org/10.1038/nrneph.2012.93
  12. Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 2011;58:374-82. https://doi.org/10.1053/j.ajkd.2011.03.020
  13. Duranton F, Rodriguez-Ortiz ME, Duny Y, Rodriguez M, Daures JP, Argiles A. Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis. Am J Nephrol 2013;37:239-48. https://doi.org/10.1159/000346846
  14. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, Schreiber MJ Jr, Simon JF, Srinivas TR, Nally JV Jr. Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD. Am J Kidney Dis 2011;58:536-43. https://doi.org/10.1053/j.ajkd.2011.04.028
  15. Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Chonchol M; HOST (Homocysteinemia in Kidney and End Stage Renal Disease) Study Investigators. Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease. Am J Kidney Dis 2012;60:567-75. https://doi.org/10.1053/j.ajkd.2012.04.014
  16. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:S1-201.
  17. Kim SM, Choi HJ, Lee JP, Kim DK, Oh YK, Kim YS, Lim CS. Prevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney disease. J Ren Nutr 2014;24:20-5. https://doi.org/10.1053/j.jrn.2013.07.003
  18. Descombes E, Fellay B, Hemett OM, Magnin JL, Fellay G. Oral postdialysis cholecalciferol supplementation in patients on maintenance hemodialysis: a dose-response approach. Int J Nephrol 2014;2014:597429.
  19. Mose FH, Vase H, Larsen T, Kancir AS, Kosierkiewic R, Jonczy B, Hansen AB, Oczachowska-Kulik AE, Thomsen IM, Bech JN, Pedersen EB. Cardiovascular effects of cholecalciferol treatment in dialysis patients--a randomized controlled trial. BMC Nephrol 2014;15:50. https://doi.org/10.1186/1471-2369-15-50
  20. Tolouian R, Rao DS, Goggins M, Bhat S, Gupta A. Seasonal variation of vitamin D in patients on hemodialysis. Clin Nephrol 2010; 74:19-24. https://doi.org/10.5414/CNP74019
  21. Chang JH, Ro H, Kim S, Lee HH, Chung W, Jung JY. Study on the relationship between serum 25-hydroxyvitamin D levels and vascular calcification in hemodialysis patients with consideration of seasonal variation in vitamin D levels. Atherosclerosis 2012;220: 563-8. https://doi.org/10.1016/j.atherosclerosis.2011.11.028
  22. Yu A, Kim J, Kwon O, Oh SY, Kim J, Yang YJ. The association between serum 25-hydroxyvitamin D concentration and consumption frequencies of vitamin D food sources in Korean adolescents. Clin Nutr Res 2013;2:107-14. https://doi.org/10.7762/cnr.2013.2.2.107
  23. Hur SJ, Kim DM, Lim KH, Yoon SH, Chung HC, Lee JS, Park J. Vitamin D levels and their relationship with cardiac biomarkers in chronic hemodialysis patients. J Korean Med Sci 2009;24 Suppl:S109-14. https://doi.org/10.3346/jkms.2009.24.S1.S109
  24. Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int 2007;11:315-21. https://doi.org/10.1111/j.1542-4758.2007.00186.x
  25. Matias PJ, Ferreira C, Jorge C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant 2009;24:611-8.
  26. Figuiredo-Dias V, Cuppari L, Garcia-Lopes MG, de Carvalho AB, Draibe SA, Kamimura MA. Risk factors for hypovitaminosis D in nondialyzed chronic kidney disease patients. J Ren Nutr 2012; 22:4-11. https://doi.org/10.1053/j.jrn.2011.02.001
  27. Park YK, Lee YJ, Lee SS. The intake of food and nutrient by the elderly with chronic disease in the Seoul area. Korean J Nutr 2012;45:531-40. https://doi.org/10.4163/kjn.2012.45.6.531
  28. Burgaz A, Akesson A, Oster A, Michaelsson K, Wolk A. Associations of diet, supplement use, and ultraviolet B radiation exposure with vitamin D status in Swedish women during winter. Am J Clin Nutr 2007;86:1399-404. https://doi.org/10.1093/ajcn/86.5.1399
  29. Russo R, Ruospo M, Cozzolino M, De Nicola L, Icardi A, Paoletti E, Mazzaferro S. Effects of vitamin D on parathyroid hormone and clinical outcomes in peritoneal dialysis: a narrative review. J Nephrol 2014;27:483-94. https://doi.org/10.1007/s40620-014-0120-x
  30. Coyne DW, Goldberg S, Faber M, Ghossein C, Sprague SM. A randomized multicenter trial of paricalcitol versus calcitriol for secondary hyperparathyroidism in stages 3-4 CKD. Clin J Am Soc Nephrol 2014;9:1620-6. https://doi.org/10.2215/CJN.10661013
  31. Lee YH, Kim JE, Roh YH, Choi HR, Rhee Y, Kang DR, Lim SK. The combination of vitamin D deficiency and mild to moderate chronic kidney disease is associated with low bone mineral density and deteriorated femoral microarchitecture: results from the KNHANES 2008-2011. J Clin Endocrinol Metab 2014;99:3879-88. https://doi.org/10.1210/jc.2013-3764
  32. Gruson D, Buglioni A, Burnett JC Jr. PTH: Potential role in management of heart failure. Clin Chim Acta 2014;433:290-6. https://doi.org/10.1016/j.cca.2014.03.029
  33. Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 2011;305:1119-27. https://doi.org/10.1001/jama.2011.308
  34. Anderson JL, Vanwoerkom RC, Horne BD, Bair TL, May HT, Lappe DL, Muhlestein JB. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am Heart J 2011;162:331-339.e2. https://doi.org/10.1016/j.ahj.2011.05.005
  35. Kestenbaum B, Katz R, de Boer I, Hoofnagle A, Sarnak MJ, Shlipak MG, Jenny NS, Siscovick DS. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 2011; 58:1433-41. https://doi.org/10.1016/j.jacc.2011.03.069
  36. Elder GJ. Vitamin D levels, bone turnover and bone mineral density show seasonal variation in patients with chronic kidney disease stage 5. Nephrology (Carlton) 2007;12:90-4.
  37. Farrar MD, Webb AR, Kift R, Durkin MT, Allan D, Herbert A, Berry JL, Rhodes LE. Efficacy of a dose range of simulated sunlight exposures in raising vitamin D status in south Asian adults: implications for targeted guidance on sun exposure. Am J Clin Nutr 2013;97:1210-6. https://doi.org/10.3945/ajcn.112.052639

Cited by

  1. Analysis of 25-Hydroxyvitamin D Status According to Age, Gender, and Seasonal Variation vol.30, pp.6, 2016, https://doi.org/10.1002/jcla.21955
  2. Déficit de vitamina D en pacientes en hemodiálisis y factores relacionados vol.21, pp.1, 2015, https://doi.org/10.4321/s2254-28842018000100003
  3. Validation of a Vitamin D Specific Questionnaire to Determine Vitamin D Status in Athletes vol.11, pp.11, 2015, https://doi.org/10.3390/nu11112732
  4. Acute Phase Proteins and Vitamin D Seasonal Variation in End-Stage Renal Disease Patients vol.9, pp.3, 2015, https://doi.org/10.3390/jcm9030807